Open-source AI predicts key peptide traits before costly lab testing
Penn Engineers have developed PeptiVerse, an AI-powered platform that predicts key chemical and biological properties of peptides, strings of amino acids whose medical potential has been demonstrated by the success of GLP-1 drugs, widely used weight-loss treatments.